Adapt Pharma is an innovative small business focused on developing cutting-edge treatments for patients with special medical conditions. Our mission is to provide simple, safe, reliable, accessible options for every patient, ensuring that patients and those who care for them have access to the right treatment at the right time. Today, our primary organizational focus is the development of a nasal spray treatment for accidental opioid overdose. We have filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for this Fast Track Designated development. The NDA has been accepted for review and granted Priority Review by the FDA. We are committed to serving as a responsible partner, collaborating with public and private stakeholders who help address the opioid overdose epidemic in the United States. Adapt Pharma's global headquarters is located in Dublin, Ireland, with the U.S. base of operations in Radnor, Pennsylvania.